期刊文献+

载脂蛋白模拟肽的研究进展 被引量:2

Research Progress of Apolipoprotein Mimetic Peptides
下载PDF
导出
摘要 载脂蛋白模拟肽是利用现代生物技术合成的与载脂蛋白功能相当而分子量更小的一类多肽。应用这类模拟肽治疗动脉粥样硬化及其相关性疾病已成为近年来心血管疾病治疗领域的研究热点。本文就载脂蛋白模拟肽最新研究进展做一综述。 Apolipoprotein mimetic peptides that mimic the function of apolipoprotein with or without bearing the sequence homology to apolipoprotein have become a hot topic of atherosclerosis therapy research.The importance of apolipoprotein mimetic peptides in atherosclerosis and related disease was established by testing in animal models,and its potential usefulness in humans has been confirmed in preliminary studies.In this article,the development of apolipoprotein mimetic peptides is reviewed.
作者 谢琼 赵水平
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第9期754-756,共3页 Chinese Journal of Arteriosclerosis
关键词 载脂蛋白模拟肽 动脉粥样硬化 高密度脂蛋白 Apolipoprotein Mimetic Peptides Atherosclerosis High Density Lipoprotein
  • 相关文献

参考文献2

二级参考文献33

  • 1庄一义.载脂蛋白A1和B的参考值及临床意义[J].中国动脉硬化杂志,2006,14(3):263-266. 被引量:35
  • 2[1]Goldberg U,Yaari S,Medalie JH.Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality.A 21-year follow-up of 8000 men[J].Arterioscler Thromb Vasc Biol,1997,17 (1):107-113.
  • 3[3]Frank PG,Marcel YL.Apolipoprotein A-I:structure-function relationships[J].J Lipid Res,2000,41 (6):853-872.
  • 4[4]Segrest JP,Jones MK,Klon AE,Sheldahl CJ,Hellinger M,De Loof H,et al.Adetailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein[J].J Biol Chem,1999,274 (45):31 755-758.
  • 5[5]Phillips JC,Wriggers W,Li Z,Jonas A,Schulten K.Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks[J].Biophys J,1997,73 (5):2 337-346.
  • 6[6]Klon AE,Jones MK,Segrest JP,Harvey SC.Molecular belt models for the apolipoprotein A-I paris and milano mutations[J].Biophys J,2000,79 (3):1679-685.
  • 7[7]Borhani DW,Engler JA,Brouillette CG.Crystallization of truncated human apolipoprotein A-I in a novel conformation[J].Acta Crystallogr D Biol Crystallogr,1999,55 (9):1 578-583.
  • 8[8]Borhani DW,Rogers DP,Engler JA,Brouillette CG.Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation[J].Proc Natl Acad Sci USA,1997,94 (23):12 291-296.
  • 9[9]Ajees AA,Anantharamaiah GM,Mishra VK,Hussain MM,Murthy HM.Crystal structure of human apolipoprotein A-I:Insights into its protective effect against cardiovascular diseases[J].Proc Natl Acad Sci USA,2006,103 (7):2 126-131.
  • 10[10]Pastore L,Belalcazar LM,Oka K,Cela R,Lee B,Chan L,et al.Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice[J].Gene,2004,327 (2):153-160.

共引文献7

同被引文献36

  • 1区景松,欧志君,Deron W.Jones,Kirkwood A.Pritchard Jr.L-4F明显改善脂蛋白氧化张力下的血管舒张功能[J].中华心血管病杂志,2004,32(10):911-914. 被引量:2
  • 2欧志君,区景松,马虹,苏诚坚,Kirkwood A,Pritchard Jr.L-4F和SC-4F在细胞培养中预防低密度脂蛋白诱导内皮功能失调的比较[J].中华心血管病杂志,2005,33(5):411-414. 被引量:2
  • 3Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study[J]. Am J Med, 1977,62(5) : 707-714.
  • 4Gordon DJ, Probstfield JL, Garrison RJ,et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies [J]. Circulation, 1989,79 ( 1 ) : 8-15.
  • 5Degoma EM, deGoma RL, Rader DJ. Beyond high-density lipoprotein cholesterol levels[J]. J Am Coll Cardiol, 2008, 51(23) :2199-2211.
  • 6Garber DW, Handattu SP, Datta G, et aI. Atherosclerosis and vascular disease effects of peptide minetics of apolipoprotein [ J ]. Curt Pham Biotechnol, 2006, 7 (4) : 235-240.
  • 7Anantharamaiah GM, Jones JL, Brouillette CG, et al. Studies of synthetic peptide analogs of the amphipathie helix. Structure of complexes with dimyristoyl phosphatidylcholine [J]. J Biol Chem, 1985, 260(18) : 10248-10255.
  • 8Mendez AJ, Anantharamaiah GM, Segrest JP, et aI. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol[J]. J Clin Invest, 1994,94(4): 1698-1705.
  • 9Navab M, Anantharamaiah GM, Reddy ST, et al. Apolipoprotein A-I mimetic peptides[J]. Arterioscler Thromb Vase Biol, 2005,25(7) : 1325-1331.
  • 10Navab M, Anantharamaiah GM, Hama S, et al. Oral administration of an apo AI mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol [ J ]. Circulation, 2002, 105(3) :290-292.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部